Annual Cash & Cash Equivalents
$11.02 M
-$1.29 M-10.48%
December 31, 2023
Summary
- As of February 7, 2025, ENTX annual cash & cash equivalents is $11.02 million, with the most recent change of -$1.29 million (-10.48%) on December 31, 2023.
- During the last 3 years, ENTX annual cash & cash equivalents has risen by +$2.43 million (+28.23%).
- ENTX annual cash & cash equivalents is now -55.73% below its all-time high of $24.89 million, reached on December 31, 2021.
Performance
ENTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$6.92 M
-$2.14 M-23.64%
September 30, 2024
Summary
- As of February 7, 2025, ENTX quarterly cash and cash equivalents is $6.92 million, with the most recent change of -$2.14 million (-23.64%) on September 30, 2024.
- Over the past year, ENTX quarterly cash and cash equivalents has dropped by -$2.27 million (-24.75%).
- ENTX quarterly cash and cash equivalents is now -74.76% below its all-time high of $27.39 million, reached on September 30, 2021.
Performance
ENTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ENTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.5% | -24.8% |
| 3 y3 years | +28.2% | -24.3% |
| 5 y5 years | +46.8% | -24.3% |
ENTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.7% | at low | -72.2% | at low |
| 5 y | 5-year | -55.7% | +28.2% | -74.8% | at low |
| alltime | all time | -55.7% | +814.4% | -74.8% | +195.5% |
Entera Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.92 M(-23.6%) |
| Jun 2024 | - | $9.06 M(-1.4%) |
| Mar 2024 | - | $9.19 M(-16.6%) |
| Dec 2023 | $11.02 M(-10.5%) | $11.02 M(+45.3%) |
| Sep 2023 | - | $7.58 M(-17.0%) |
| Jun 2023 | - | $9.13 M(-14.6%) |
| Mar 2023 | - | $10.69 M(-13.1%) |
| Dec 2022 | $12.31 M(-50.6%) | $12.31 M(-14.1%) |
| Sep 2022 | - | $14.32 M(-17.1%) |
| Jun 2022 | - | $17.28 M(-14.1%) |
| Mar 2022 | - | $20.11 M(-19.2%) |
| Dec 2021 | $24.89 M(+189.7%) | $24.89 M(-9.1%) |
| Sep 2021 | - | $27.39 M(+1.7%) |
| Jun 2021 | - | $26.93 M(+64.4%) |
| Mar 2021 | - | $16.38 M(+90.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $8.59 M(-43.4%) | $8.59 M(+21.6%) |
| Sep 2020 | - | $7.07 M(-27.6%) |
| Jun 2020 | - | $9.77 M(-26.7%) |
| Mar 2020 | - | $13.33 M(-12.2%) |
| Dec 2019 | $15.19 M(+102.3%) | $15.19 M(+157.1%) |
| Sep 2019 | - | $5.91 M(-20.0%) |
| Jun 2019 | - | $7.39 M(+33.9%) |
| Mar 2019 | - | $5.52 M(-26.5%) |
| Dec 2018 | $7.51 M(-36.1%) | $7.51 M(-45.8%) |
| Sep 2018 | - | $13.86 M(+114.2%) |
| Jun 2018 | - | $6.47 M(-44.9%) |
| Dec 2017 | $11.75 M(+182.2%) | $11.75 M(+305.2%) |
| Sep 2017 | - | $2.90 M(+23.9%) |
| Jun 2017 | - | $2.34 M(-43.8%) |
| Dec 2016 | $4.16 M(+245.5%) | $4.16 M |
| Dec 2015 | $1.21 M | - |
FAQ
- What is Entera Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Entera Bio?
- What is Entera Bio annual cash & cash equivalents year-on-year change?
- What is Entera Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Entera Bio?
- What is Entera Bio quarterly cash and cash equivalents year-on-year change?
What is Entera Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of ENTX is $11.02 M
What is the all time high annual cash & cash equivalents for Entera Bio?
Entera Bio all-time high annual cash & cash equivalents is $24.89 M
What is Entera Bio annual cash & cash equivalents year-on-year change?
Over the past year, ENTX annual cash & cash equivalents has changed by -$1.29 M (-10.48%)
What is Entera Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ENTX is $6.92 M
What is the all time high quarterly cash and cash equivalents for Entera Bio?
Entera Bio all-time high quarterly cash and cash equivalents is $27.39 M
What is Entera Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, ENTX quarterly cash and cash equivalents has changed by -$2.27 M (-24.75%)